If you have an immunodeficiency related to certain infections, inflammatory diseases, or autoimmune disorders, you may have heard about an infusion treatment called intravenous immunoglobulin, or IVIG ...

Intravenous immunoglobulin (IVIG) is donor-derived antibodies used in myasthenia gravis (MG) for fast symptom control. It’s used for flares, maintenance, bridging slower therapies, or pre-surgery ...

Intravenous immunoglobulin (IVIG) is used to replenish immunoglobulins in hypogammaglobulinemia (HG) caused by hematologic malignancies (HM) or their treatment (autologous stem-cell transplantation ...

For people living with primary immunodeficiency (PI), immunoglobulin replacement therapy (Ig) is a cornerstone of treatment. It helps prevent serious infections, reduces hospitalizations, and supports ...

The administration of intravenous immune globulin (IVIG) is an established treatment for deficiency states and other immune-mediated disorders. It is used extensively in patients with neurologic ...

Since the sudden emergence of multisystem inflammatory disease in children (MIS-C) in April 2020 as a novel and severe presentation of coronavirus disease 2019 (Covid-19), nearly 4000 cases of MIS-C ...

With use of intravenous immune globulin (IVIg) for the treatment of adults with dermatomyositis, a significantly higher percentage of patients experienced at least minimal improvement in disease ...

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated neurological disease characterized by progressive weakness in the distal limbs and paresthesias caused by damage ...

Advances in our understanding of the pathogenesis of rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of immunoglobulin-based therapy as a ...

Intravenous immunoglobulin (IVIg) treatment can help you fight off infections if you have a weakened immune system or other diseases. Some people may have IVIg instead of other medications (such as ...

Plant-based diet trends in oncology patients. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a full text component.